Standard of care in immunotherapy trials: Challenges and considerations

Por Rivalland, Gareth, Scott, Andrew M., John, Thomas
Publicado no Hum Vaccin Immunother (2017)

A Possible Role for Metallic Ions in the Carbohydrate Cluster Recognition Displayed by a Lewis Y Specific Antibody

Por Farrugia, William, Scott, Andrew M., Ramsland, Paul A.
Publicado em 2009

Monoclonal antibodies in cancer therapy

Por Scott, Andrew M., Allison, James P., Wolchok, Jedd D.
Publicado em 2012

Generalized Lymph Node Activation after Influenza Vaccination on (18)F FDG-PET/CT Imaging, an Important Pitfall in PET Interpretation

Por Ayati, Narjess, Jesudason, Sarah, Berlangieri, Salvatore U., Scott, Andrew M.
Publicado no Asia Ocean J Nucl Med Biol (2017)

Antibody–Drug Conjugates for Cancer Therapy

Por Parslow, Adam C., Parakh, Sagun, Lee, Fook-Thean, Gan, Hui K., Scott, Andrew M.
Publicado no Biomedicines (2016)

Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-κB and initiates tumour vascular normalization

Por Gan, Hui K, Lappas, Martha, Cao, Diana X, Cvrljevdic, Anna, Scott, Andrew M, Johns, Terrance G
Publicado no J Cell Mol Med (2009)

Fully automated synthesis of [(18)F]fluoro-dihydrotestosterone ([(18)F]FDHT) using the FlexLab module

Por Ackermann, Uwe, Lewis, Jason S, Young, Kenneth, Morris, Michael J, Weickhardt, Andrew, Davis, Ian, Scott, Andrew M
Publicado no J Labelled Comp Radiopharm (2016)

Impact on product quality of high productive GS-CHO cell lines

Por Perani, Angelo, Gloria, Benjamin, Wang, Dongmao, Murphy, Roger, Singh, Harjit Khangura, Smyth, Fiona E, Scott, Andrew M
Publicado em 2011

Evaluation of an online biomass probe to monitor cell growth and cell death

Por Perani, Angelo, Gloria, Benjamin, Wang, Dongmao, Buffier, Anne-Sophie, Berteau, Olivier, Esteban, Geoffrey, Smyth, Fiona E, Scott, Andrew M
Publicado em 2011

Therapeutic efficacy of (177)Lu-CHX-A″-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy

Por Kelly, Marcus P, Lee, Sze Ting, Lee, F-T, Smyth, Fiona E, Davis, Ian D., Brechbiel, Martin W, Scott, Andrew M
Publicado em 2009

Antibodies binding the ADAM10 substrate recognition domain inhibit Eph function

Por Atapattu, Lakmali, Saha, Nayanendu, Llerena, Carmen, Vail, Mary E., Scott, Andrew M., Nikolov, Dimitar B., Lackmann, Martin, Janes, Peter W.
Publicado em 2012

Efficiency of T-cell costimulation by CD80 and CD86 cross-linking correlates with calcium entry

Por Thiel, Markus, Wolfs, Melodie-Jo, Bauer, Stefan, Wenning, Anna S, Burckhart, Tanja, Schwarz, Eva C, Scott, Andrew M, Renner, Christoph, Hoth, Markus
Publicado em 2010

Tumor Targeting by a Multivalent Single-Chain Fv (scFv) Anti-Lewis Y Antibody Construct

Por Kelly, Marcus P., Lee, F.-T., Tahtis, Kiki, Power, Barbara E., Smyth, Fiona E., Brechbiel, Martin W., Hudson, Peter J., Scott, Andrew M.
Publicado em 2008

The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases

Por Pillay, Vinochani, Allaf, Layal, Wilding, Alexander L, Donoghue, Jacqui F, Court, Naomi W, Greenall, Steve A, Scott, Andrew M, Johns, Terrance G
Publicado em 2009

Identification and characterization of EGF receptor in individual exosomes by fluorescence-activated vesicle sorting

Por Higginbotham, James N., Zhang, Qin, Jeppesen, Dennis K., Scott, Andrew M., Manning, H. Charles, Ochieng, Josiah, Franklin, Jeffrey L., Coffey, Robert J.
Publicado no J Extracell Vesicles (2016)

Internalization, Intracellular Trafficking, and Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody

Por Perera, Rushika M, Zoncu, Roberto, Johns, Terrance G, Pypaert, Marc, Lee, Fook-Thean, Mellman, Ira, Old, Lloyd J, Toomre, Derek K, Scott, Andrew M
Publicado em 2007

A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells

Por Solomon, Benjamin J., Desai, Jayesh, Rosenthal, Mark, McArthur, Grant A., Pattison, Scott T., Pattison, Stacey L., MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Scott, Andrew M.
Publicado no PLoS One (2015)

Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET

Por Greenall, Sameer A., Gherardi, Ermanno, Liu, Zhanqi, Donoghue, Jacqueline F., Vitali, Angela A., Li, Qian, Murphy, Roger, Iamele, Luisa, Scott, Andrew M., Johns, Terrance G.
Publicado em 2012

Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

Por Greening, David W., Lee, Sze Ting, Ji, Hong, Simpson, Richard J., Rigopoulos, Angela, Murone, Carmel, Fang, Catherine, Gong, Sylvia, O'Keefe, Graeme, Scott, Andrew M.
Publicado no Oncotarget (2015)

Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

Por Greening, David W., Lee, Sze Ting, Ji, Hong, Simpson, Richard J., Rigopoulos, Angela, Murone, Carmel, Fang, Catherine, Gong, Sylvia, O'Keefe, Graeme, Scott, Andrew M.
Publicado no Oncotarget (2016)